Topical management of actinic keratosis and field cancerisation

Giornale Italiano di Dermatologia e Venereologia

Volumn 144, Issue 4, 2009, Pages 459-462

  Stockfleth, E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Actinic; Carcinoma; Keratosis; Skin diseases; Squamous cell

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FLUOROURACIL; HYALURONIC ACID; IMIQUIMOD;

ACTINIC KERATOSIS; CANCER GROWTH; CANCER RECURRENCE; CARCINOMA IN SITU; DESICCATION; EARLY DIAGNOSIS; ERYTHEMA; FIELD CANCERIZATION; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; LIFESTYLE; PHOTODYNAMIC THERAPY; RADIATION EXPOSURE; REVIEW; SCAR FORMATION; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; ULTRAVIOLET RADIATION;

EID: 72249108186     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. British Association of Dermatology website [Homepage]. [cited 2009 July 29]. Available at: www.bad.org.uk
2. Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000;142:1154-1159 (Pubitemid 30418302)
3. Callen JP, Bickers DR, Moy RL. Actinic keratoses. J Am Acad Dermatol 1997;36:650-653
4. Cancer Research UK website [Homepage]. [cited 2009 July 29]. Available at: www.cancer.org.uk
5. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-1730
6. Stockfleth E. Actinic keratoses. Cancer Treat Res 2009;146:227-239
7. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000;19:19-27. (Pubitemid 32004688)
8. Stockfleth E, Ulrich C, Meyer T, Christophers E. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002;160:251-258
9. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996;61:715-721
10. The European Dermatology Forum. EDF guidelines. Guidelines for the management of Actinic Keratoses [Internet]. [cited 2009 July 29]. Available at: http://www.euroderm.org/content/guidelines-keratoses.htm
11. Chiarello SE. Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison. Dermatol Surg 2000;26:728-732
12. Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville-Nash PR, Willis D et al. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofen. Cancer Res 1999;57:1625-1629
13. Nickoloff BJ, Qin JZ, Chaturvedi V, Bacon P, Panella J, Denning MF. Life and death signaling pathways contributing to skin cancer. J Investig Dermatol Symp Proc 2002;7:27-35. (Pubitemid 36151091)
14. Klenk F et al. BMC Cancer 2006;9:1471-2407.
15. Shire Pharmaceuticals. Solaraze summary of product characteristics, October 2004.
16. Wolf JE Jr, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001;40:709-713 (Pubitemid 34023642)
17. Smith SR, Morhenn VB, Piacquadio DJ. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatology 2006;5:156-159
18. Gupta AK. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation. Cutis 2002;70:30-36
19. Salasche SJ, Levine N, Morrison L. Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial. J American Academy Dermatology 2002;47:571-577
20. Stockfleth E, Ulrich C, Hauschild A, Lischner S, Meyer T, Christophers E. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol 2002;12:569-572 (Pubitemid 35440796)